Lisa White, in Alda, NE - Counselor

Lisa White, is a Counselor - Mental Health based in Alda, Nebraska. Lisa White is licensed to practice in Nebraska (license number 10970) and her current practice location is 4385 W Stolley Park Rd, Alda, Nebraska. She can be reached at her office (for appointments etc.) via phone at (308) 383-1622.

NPI number for Lisa White is 1114472917 and her current mailing address is 4385 W Stolley Park Rd, Alda, Nebraska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1114472917.

Contact Information

	Lisa White,
	4385 W Stolley Park Rd, Alda, NE 68810-9798
	(308) 383-1622
	Not Available

Healthcare Provider's Profile

Full Name	Lisa White
Gender	Female
Speciality	Counselor - Mental Health
Location	4385 W Stolley Park Rd, Alda, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1114472917
Provider Enumeration Date: 08/22/2016
Last Update Date: 08/22/2016

Medical Identifiers

Medical identifiers for Lisa White such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1114472917	NPI	-	NPPES
13879032	Other	NE	CAQH

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YA0400X	Counselor - Addiction (substance Use Disorder)	P-1375 (Nebraska)	Secondary
101YM0800X	Counselor - Mental Health	10970 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lisa White is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Lisa White, 4385 W Stolley Park Rd, Alda, NE 68810-9798 Ph: () -	Lisa White, 4385 W Stolley Park Rd, Alda, NE 68810-9798 Ph: (308) 383-1622

News Archive

Enobia announces positive results from ENB-0040 Phase II juvenile clinical trial for hypophosphatasia

Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.

Sexually explicit television makes teens more sexually active

Teens who watch lots of sexually explicit television programs are about twice as likely to become sexually active as those who don't watch the television shows, an article in this month's Pediatrics reports.

China Nepstar Chain Drugstore first-quarter revenue increases 12.1% to $83 million

China Nepstar Chain Drugstore Ltd., the largest drugstore chain in China in terms of the number of directly operated stores, with 2,559 directly operated stores in operation as of March 31, 2010, today announced its unaudited financial results for the first quarter ended March 31, 2010.

Symposium to examine bidirectional relationship between oral health and diabetes

Some 65 percent of people in the US have periodontal disease, but that rate jumps to 90 percent among individuals with diabetes. While the links between oral disease and other systemic health issues are now well known, there continues to be little to no connection between medical and dental care for diabetic patients.

Lisa White, - Counselor in Alda, NE